NEW YORK, Feb. 6, 2012  /-  Reportlinker.com announces that a new market research report is available in its catalogue: Generic Pharmaceuticals Market - A Global Analysis http://www.reportlinker.com/p0769015/Generic-Pharmaceuticals-Market---A-Global-Analysis.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pharmaceutical The research service aim...

NEW YORK, Feb. 6, 2012  /-  Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical and Biotech Contract Manufacturing Markets http://www.reportlinker.com/p0769017/European-Pharmaceutical-and-Biotech-Contract-Manufacturing-Markets.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Manufactur...

NEW YORK, Feb. 6, 2012 /- Reportlinker.com announces that a new market research report is available in its catalogue: World Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals) http://www.reportlinker.com/p0769020/World-Market-for-Anti-Infectives-Antifungals-Antibacterials-and-Antivirals- .html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Dru...

SAN ANTONIO, Feb. 3, 2012 /- Mission Pharmacal Company recently acquired the prescription barrier cream Eletone® Cream, from Ferndale Healthcare, Inc. of Ferndale, Michigan.  Eletone Cream is a non-steroidal, barrier cream approved by the Food and Drug Administration for the long term treatment of atopic dermatitis, an inflammatory, chronically relapsing, non-con...

RIDGEFIELD, Conn., Feb. 3, 2012 /- Boehringer Ingelheim presented results of a drug interaction study that found Aggrenox® (aspirin/extended-release dipyridamole), an antiplatelet medication, is not affected by the co-administration of omeprazole, a proton pump inhibitor (PPI), frequently used to treat several gastrointestinal conditions. These data were presented at the Intern...

CHAPEL HILL, N.C., Feb. 3, 2012 /- Cempra, Inc. (Nasdaq: CEMP ), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, today announced the pricing of its initial public offering of 8,400,000 shares of its common stock at a price to the public of $6.00 per share.  Cempra...

PARSIPPANY, N.J., Feb. 3, 2012 /- In response to investment community speculation following release of the transcript of a pre-trial conference call related to its Lidoderm ® patent challenge, Watson Pharmaceuticals, Inc. (NYSE: WPI ) today issued the following statement: "Watson's abbreviated new drug application (ANDA) for a generic version of Lidoderm remains on track....

SHENYANG, China, Feb. 3, 2012 /PRNewswire-Asia-FirstCall/ --  3SBio Inc. (NASDAQ: SSRX ) ("3SBio"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it will release its unaudited fourth  quarter and full year  2011 results after the NASDAQ stock market closes on Thursday...

LOVELAND, Colo., Feb. 3, 2012 /- Heska Corporation (Nasdaq: HSKA ) announces the following Webcast: What: Heska Corporation Invites You to Join Its Fourth Quarter and Year-End 2011 Earnings Conference Call on the Web   When: Friday, February 17, 2012 @ 9:00 a.m. (MST)   Where: www.heska.com (click on the Q4 and Year-End 2011 Earnings Ca...

SAN DIEGO, Feb. 3, 2012 /-  Tocagen Inc. today announced the publication of data showing the company's investigational treatment for high grade glioma eradicates brain tumors and provides a dramatic survival benefit in mouse models of glioblastoma. Almost all mice receiving the top dose of Toca 511 followed by 5-FC were still alive at 180 days, which was the termination date f...

CAMBRIDGE, Mass., Feb. 3, 2012 /- Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX ), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced that it has received notification from the U.S. Food and Drug Administration (FDA) that the partial clinical hold on IDX184 has been removed and that the Company...

CHADDS FORD, Pa., Feb. 3, 2012 /- Endo Pharmaceuticals Holdings (Nasdaq: ENDP ) will announce its fourth quarter and full year 2011 financial results on February 24, 2012 and will host a conference call and webcast at 8:30 a.m. ET that day to discuss these results.  David P. Holveck, president and CEO of Endo, Julie McHugh, chief operating officer, Dr. Ivan Gergel, executiv...

PARIS, February 3, 2012 /- 'SARAH' - a French national collaborative randomized controlled trial of radioembolization with yttrium-90 resin microspheres versus sorafenib in advanced hepatocellular carcinoma is now open for recruitment The start of SARAH, a new randomized controlled trial to directly compare the effectiveness of radioembolization with yttrium-90 resin microsphere...

SAN DIEGO, Feb. 2, 2012 /- CareFusion Corp. (NYSE: CFN ), a leading, global medical technology company, today reported results for the three and six months ended Dec. 31, 2011.   "Our second quarter results were led by strong performance across the Medical Systems segment, with our three major businesses achieving positive gains and positioning us well for the second half o...

KALAMAZOO, Mich., Feb. 2, 2012 /- On February 2, at the Late-Breaking Science Session at the International Stroke Conference, Stryker announced the results of the TREVO Study ( T hrombectomy RE vascularization of large V essel O cclusions in acute ischemic stroke). This was one of the first prospective, multi-center clinical studies of clot-removing stent retriever t...

BOSTON, Feb. 2, 2012 /PRNewswire-USNewswire/ -- On February 14 from 1 to 5 p.m., Children's Hospital Boston, will hosts its first "Innovation Day." In a series of 17 short sessions , cutting-edge approaches to improving care delivery and quality while lowering costs will be presented by the innovative leaders at Children's Hospital Boston. The event is sponsored by the Innovation Acceleratio...

NEWTOWN SQUARE, Pa., Feb. 2, 2012 /- On Jan. 23, IUE/CWA Local 81408, the optical workers union that represents associates at Davis Vision's Newtown Square eyeglass manufacturing facility, went on strike. This move has not been endorsed by the international union (IUE/CWA). Although 115 employees are covered under the bargaining unit contract, 32 have continued to work. According...

LAS VEGAS, Feb. 2, 2012 /-  American Pacific Corporation (Nasdaq: APFC ) ("AMPAC") announced today that it will release its Fiscal 2012 first quarter financial results on Wednesday, February 8, 2012, immediately after the stock market closes. Joseph Carleone, President and Chief Executive Officer and Dana Kelley, Vice President, Chief Financial Officer and Treasurer, will...

ALEXANDRIA, Va., Feb. 2, 2012 /PRNewswire-USNewswire/ -- The head of the Senate's antitrust subcommittee voiced major concerns today over the proposed mega-merger of prescription drug middlemen Express Scripts and Medco, and the National Community Pharmacists Association (NCPA) saluted the lawmaker's efforts. (Logo: http://photos.prnewswire.com/prnh/20100106/DC33253LOGO ) Senator Herb Ko...

Lynchburg, Va. and Raleigh, N.C., Feb. 2 , 2012 /- TeleHealth Services, the nation's leading provider of healthcare-grade televisions and interactive patient education solutions, today announced that it has partnered with Centra Health (Centra) to deploy the TIGR interactive patient education system across the health system's acute care facilities. Centra is a technology driv...